Allianz Asset Management
SUPN icon

Allianz Asset Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Allianz Asset Management’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-14,700
Closed -$501K – 2249
2024
Q1 		$501K Hold
14,700
– – ﹤0.01% 1627
2023
Q4 		$425K Hold
14,700
– – ﹤0.01% 1905
2023
Q3 		$405K Hold
14,700
– – ﹤0.01% 1992
2023
Q2 		$442K Buy
+14,700
New +$514K ﹤0.01% 1767
2019
Q2 		– Sell
-137,241
Closed -$4.81M – 2760
2019
Q1 		$4.81M Buy
137,241
+37,271
+37% +$1.39M ﹤0.01% 1478
2018
Q4 		$3.32M Sell
99,970
-98,052
-50% -$4.22M ﹤0.01% 1577
2018
Q3 		$9.97M Buy
198,022
+27,205
+16% +$1.34M 0.01% 1271
2018
Q2 		$10.2M Sell
170,817
-107,884
-39% -$5.59M 0.01% 1244
2018
Q1 		$12.8M Buy
278,701
+104,829
+60% +$4.37M 0.01% 1132
2017
Q4 		$6.93M Buy
173,872
+16,251
+10% +$642K 0.01% 1490
2017
Q3 		$6.3M Sell
157,621
-174,121
-52% -$7.54M 0.01% 1513
2017
Q2 		$14.3M Sell
331,742
-209,416
-39% -$7.45M 0.01% 1149
2017
Q1 		$16.9M Buy
541,158
+18,858
+4% +$505K 0.02% 1089
2016
Q4 		$13.2M Sell
522,300
-74,981
-13% -$1.68M 0.01% 1233
2016
Q3 		$14.8M Buy
597,281
+221,857
+59% +$5.02M 0.01% 1132
2016
Q2 		$7.65M Sell
375,424
-279,316
-43% -$4.95M 0.01% 1341
2016
Q1 		$9.98M Sell
654,740
-1,376
-0.2% -$18K 0.01% 1124
2015
Q4 		$8.82M Sell
656,116
-29
-0% -$449 0.01% 1112
2015
Q3 		$9.21M Buy
656,145
+11,798
+2% +$219K 0.01% 1020
2015
Q2 		$10.9M Buy
644,347
+418,485
+185% +$5.96M 0.01% 1056
2015
Q1 		$2.73M Buy
225,862
+8,024
+4% +$75.8K ﹤0.01% 1427
2014
Q4 		$1.81M Buy
217,838
+12,561
+6% +$106K ﹤0.01% 1595
2014
Q3 		$1.78M Sell
205,277
-16,023
-7% -$145K ﹤0.01% 1476
2014
Q2 		$2.42M Buy
+221,300
New +$1.97M ﹤0.01% 1131

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Allianz Asset Management's SUPN Position: Q2 2024 in Review

Allianz Asset Management sold out of Supernus Pharmaceuticals (SUPN) in Q2 2024, closing a stake of 14,700 shares — an estimated $501K sold.

Allianz Asset Management first reported a position in SUPN in Q2 2014 and held it in 24 quarters. The position peaked at $16.9M in Q1 2017. 244 funds tracked by Wall St. Rank hold SUPN as of Q2 2024.

  • Allianz Asset Management reported no remaining Supernus Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Allianz Asset Management sold 14,700 Supernus Pharmaceuticals shares in Q2 2024, an estimated $501K.
  • Allianz Asset Management first reported a position in Supernus Pharmaceuticals in Q2 2014 and held it in 24 quarters.
  • Allianz Asset Management's Supernus Pharmaceuticals position peaked at $16.9M in Q1 2017.
  • 244 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2024.

Based on Allianz Asset Management's 13F filing for Q2 2024, filed 13 Aug 2024.